Loading…

Antimicrobial susceptibility and molecular characteristics of methicillin-resistant Staphylococcus aureus in a Japanese secondary care facility

Abstract Methicillin-resistant Staphylococcus aureus (MRSA) is prevalent in Japan, and the Staphylococcus cassette chromosome mec (SCC mec ) type II is common among hospital-acquired MRSA isolates. Information pertaining to MRSA characteristics is limited, including SCC mec types, in primary or seco...

Full description

Saved in:
Bibliographic Details
Published in:Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy 2016-01, Vol.22 (1), p.14-18
Main Authors: Kimura, Yumiko, Morinaga, Yoshitomo, Akamatsu, Norihiko, Matsuda, Junichi, Yamaryo, Takeshi, Kawakami, Kenji, Matsuo, Hidenori, Kosai, Kosuke, Uno, Naoki, Hasegawa, Hiroo, Yanagihara, Katsunori
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c563t-7c2f487a9d93f0b065cb33188679f9846dfdd6a54b84f0c40d1724095e8de1e63
cites cdi_FETCH-LOGICAL-c563t-7c2f487a9d93f0b065cb33188679f9846dfdd6a54b84f0c40d1724095e8de1e63
container_end_page 18
container_issue 1
container_start_page 14
container_title Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy
container_volume 22
creator Kimura, Yumiko
Morinaga, Yoshitomo
Akamatsu, Norihiko
Matsuda, Junichi
Yamaryo, Takeshi
Kawakami, Kenji
Matsuo, Hidenori
Kosai, Kosuke
Uno, Naoki
Hasegawa, Hiroo
Yanagihara, Katsunori
description Abstract Methicillin-resistant Staphylococcus aureus (MRSA) is prevalent in Japan, and the Staphylococcus cassette chromosome mec (SCC mec ) type II is common among hospital-acquired MRSA isolates. Information pertaining to MRSA characteristics is limited, including SCC mec types, in primary or secondary care facilities. A total of 128 MRSA isolates (90 skin and soft tissue isolates and 38 blood isolates) were collected at a secondary care facility, Kawatana Medical Center, from 2005 to 2011. Antimicrobial susceptibility testing for anti-MRSA antibiotics and molecular testing for SCC mec and virulence genes ( tst , sec , etb , luk S/F-PV) were performed. Strains positive for luk S/F-PV were analyzed by multilocus sequence typing and phage open-reading frame typing. SCC mec typing in skin and soft tissue isolates revealed that 65.6% had type IV, 22.2% had type II, 8.9% had type I, and 3.3% had type III. In blood isolates, 50.0% had type IV, 47.4% had type II, and 2.6% had type III. Minimum inhibitory concentrations, MIC50 /MIC90 , against vancomycin, teicoplanin, linezolid, and arbekacin increased slightly in SCC mec II isolates from skin and soft tissue. MICs against daptomycin were similar between sites of isolation. SCC mec type II isolates possess tst and sec genes at a greater frequently than SCC mec type IV isolates. Four luk S/F-PV-positive isolates were divided into two clonal patterns and USA300 was not included. In conclusion, SCC mec type IV was dominant in blood, skin, and soft tissue isolates in a secondary care facility in Japan. Because antimicrobial susceptibility varies with the SCC mec type, SCC mec typing of clinical isolates should be monitored in primary or secondary care facilities.
doi_str_mv 10.1016/j.jiac.2015.08.011
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1794498849</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1341321X15001944</els_id><sourcerecordid>1794498849</sourcerecordid><originalsourceid>FETCH-LOGICAL-c563t-7c2f487a9d93f0b065cb33188679f9846dfdd6a54b84f0c40d1724095e8de1e63</originalsourceid><addsrcrecordid>eNqNUs2K1jAULaI4P_oCLiRLN61JkzYpiDAM6igDLkbBXUhvbvlS0x-TVPiewlc29RtduBBXN5BzTnLPOUXxjNGKUda-HKvRGahqypqKqooy9qA4Z4LLUkpFH-YzF6zkNftyVlzEOFLKZKPU4-KsblsmuejOix9Xc3KTg7D0zngStwi4Jtc779KRmNmSafEImzeBwMEEAwmDi8lBJMtAJkwHB857N5cBY74wcyJ3yayHo19gAdgiMVvAPNxMDPlgVjNjRBIRltmacCRgApLBwK8nnxSPBuMjPr2fl8Xnt28-Xd-Utx_fvb--ui2haXkqJdSDUNJ0tuMD7WnbQM85U6qV3dAp0drB2tY0oldioCCoZbIWtGtQWWTY8svixUl3Dcu3DWPSk8ure59_t2xRM9kJ0Skluv-ANlTUSjU8Q-sTNPsZY8BBr8FNeUnNqN4z06PeM9N7ZpoqnTPLpOf3-ls_of1D-R1SBrw6ATAb8t1h0BEczoDWBYSk7eL-rf_6LzrkuBwY_xWPGMdlC3O2WjMda0313d6avTSsyYXJLvCf0jHAWQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1750428853</pqid></control><display><type>article</type><title>Antimicrobial susceptibility and molecular characteristics of methicillin-resistant Staphylococcus aureus in a Japanese secondary care facility</title><source>ScienceDirect Freedom Collection</source><creator>Kimura, Yumiko ; Morinaga, Yoshitomo ; Akamatsu, Norihiko ; Matsuda, Junichi ; Yamaryo, Takeshi ; Kawakami, Kenji ; Matsuo, Hidenori ; Kosai, Kosuke ; Uno, Naoki ; Hasegawa, Hiroo ; Yanagihara, Katsunori</creator><creatorcontrib>Kimura, Yumiko ; Morinaga, Yoshitomo ; Akamatsu, Norihiko ; Matsuda, Junichi ; Yamaryo, Takeshi ; Kawakami, Kenji ; Matsuo, Hidenori ; Kosai, Kosuke ; Uno, Naoki ; Hasegawa, Hiroo ; Yanagihara, Katsunori</creatorcontrib><description>Abstract Methicillin-resistant Staphylococcus aureus (MRSA) is prevalent in Japan, and the Staphylococcus cassette chromosome mec (SCC mec ) type II is common among hospital-acquired MRSA isolates. Information pertaining to MRSA characteristics is limited, including SCC mec types, in primary or secondary care facilities. A total of 128 MRSA isolates (90 skin and soft tissue isolates and 38 blood isolates) were collected at a secondary care facility, Kawatana Medical Center, from 2005 to 2011. Antimicrobial susceptibility testing for anti-MRSA antibiotics and molecular testing for SCC mec and virulence genes ( tst , sec , etb , luk S/F-PV) were performed. Strains positive for luk S/F-PV were analyzed by multilocus sequence typing and phage open-reading frame typing. SCC mec typing in skin and soft tissue isolates revealed that 65.6% had type IV, 22.2% had type II, 8.9% had type I, and 3.3% had type III. In blood isolates, 50.0% had type IV, 47.4% had type II, and 2.6% had type III. Minimum inhibitory concentrations, MIC50 /MIC90 , against vancomycin, teicoplanin, linezolid, and arbekacin increased slightly in SCC mec II isolates from skin and soft tissue. MICs against daptomycin were similar between sites of isolation. SCC mec type II isolates possess tst and sec genes at a greater frequently than SCC mec type IV isolates. Four luk S/F-PV-positive isolates were divided into two clonal patterns and USA300 was not included. In conclusion, SCC mec type IV was dominant in blood, skin, and soft tissue isolates in a secondary care facility in Japan. Because antimicrobial susceptibility varies with the SCC mec type, SCC mec typing of clinical isolates should be monitored in primary or secondary care facilities.</description><identifier>ISSN: 1341-321X</identifier><identifier>EISSN: 1437-7780</identifier><identifier>DOI: 10.1016/j.jiac.2015.08.011</identifier><identifier>PMID: 26617349</identifier><language>eng</language><publisher>Netherlands: Elsevier Ltd</publisher><subject>Anti-Bacterial Agents - therapeutic use ; Bacterial Proteins - blood ; Bacterial Toxins ; Community-acquired methicillin-resistant Staphylococcus aureus ; Cross Infection - blood ; Cross Infection - drug therapy ; Cross Infection - microbiology ; Daptomycin - therapeutic use ; Dibekacin - analogs &amp; derivatives ; Dibekacin - therapeutic use ; Exotoxins ; Hematology, Oncology and Palliative Medicine ; Humans ; Japan ; Leukocidins ; Linezolid - therapeutic use ; Methicillin-Resistant Staphylococcus aureus - genetics ; Microbial Sensitivity Tests ; Multilocus Sequence Typing ; Open Reading Frames ; Panton-Valentine leukocidin ; Phage open reading frame typing ; Recombinases - blood ; SCCmec type ; Secondary Care Centers ; Skin - microbiology ; Soft Tissue Infections - microbiology ; Staphylococcus aureus ; Staphylococcus aureus - genetics ; Staphylococcus aureus - isolation &amp; purification ; Teicoplanin - therapeutic use ; Vancomycin - therapeutic use ; Virulence Factors</subject><ispartof>Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2016-01, Vol.22 (1), p.14-18</ispartof><rights>Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases</rights><rights>2015 Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases</rights><rights>Copyright © 2015 Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c563t-7c2f487a9d93f0b065cb33188679f9846dfdd6a54b84f0c40d1724095e8de1e63</citedby><cites>FETCH-LOGICAL-c563t-7c2f487a9d93f0b065cb33188679f9846dfdd6a54b84f0c40d1724095e8de1e63</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/26617349$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Kimura, Yumiko</creatorcontrib><creatorcontrib>Morinaga, Yoshitomo</creatorcontrib><creatorcontrib>Akamatsu, Norihiko</creatorcontrib><creatorcontrib>Matsuda, Junichi</creatorcontrib><creatorcontrib>Yamaryo, Takeshi</creatorcontrib><creatorcontrib>Kawakami, Kenji</creatorcontrib><creatorcontrib>Matsuo, Hidenori</creatorcontrib><creatorcontrib>Kosai, Kosuke</creatorcontrib><creatorcontrib>Uno, Naoki</creatorcontrib><creatorcontrib>Hasegawa, Hiroo</creatorcontrib><creatorcontrib>Yanagihara, Katsunori</creatorcontrib><title>Antimicrobial susceptibility and molecular characteristics of methicillin-resistant Staphylococcus aureus in a Japanese secondary care facility</title><title>Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy</title><addtitle>J Infect Chemother</addtitle><description>Abstract Methicillin-resistant Staphylococcus aureus (MRSA) is prevalent in Japan, and the Staphylococcus cassette chromosome mec (SCC mec ) type II is common among hospital-acquired MRSA isolates. Information pertaining to MRSA characteristics is limited, including SCC mec types, in primary or secondary care facilities. A total of 128 MRSA isolates (90 skin and soft tissue isolates and 38 blood isolates) were collected at a secondary care facility, Kawatana Medical Center, from 2005 to 2011. Antimicrobial susceptibility testing for anti-MRSA antibiotics and molecular testing for SCC mec and virulence genes ( tst , sec , etb , luk S/F-PV) were performed. Strains positive for luk S/F-PV were analyzed by multilocus sequence typing and phage open-reading frame typing. SCC mec typing in skin and soft tissue isolates revealed that 65.6% had type IV, 22.2% had type II, 8.9% had type I, and 3.3% had type III. In blood isolates, 50.0% had type IV, 47.4% had type II, and 2.6% had type III. Minimum inhibitory concentrations, MIC50 /MIC90 , against vancomycin, teicoplanin, linezolid, and arbekacin increased slightly in SCC mec II isolates from skin and soft tissue. MICs against daptomycin were similar between sites of isolation. SCC mec type II isolates possess tst and sec genes at a greater frequently than SCC mec type IV isolates. Four luk S/F-PV-positive isolates were divided into two clonal patterns and USA300 was not included. In conclusion, SCC mec type IV was dominant in blood, skin, and soft tissue isolates in a secondary care facility in Japan. Because antimicrobial susceptibility varies with the SCC mec type, SCC mec typing of clinical isolates should be monitored in primary or secondary care facilities.</description><subject>Anti-Bacterial Agents - therapeutic use</subject><subject>Bacterial Proteins - blood</subject><subject>Bacterial Toxins</subject><subject>Community-acquired methicillin-resistant Staphylococcus aureus</subject><subject>Cross Infection - blood</subject><subject>Cross Infection - drug therapy</subject><subject>Cross Infection - microbiology</subject><subject>Daptomycin - therapeutic use</subject><subject>Dibekacin - analogs &amp; derivatives</subject><subject>Dibekacin - therapeutic use</subject><subject>Exotoxins</subject><subject>Hematology, Oncology and Palliative Medicine</subject><subject>Humans</subject><subject>Japan</subject><subject>Leukocidins</subject><subject>Linezolid - therapeutic use</subject><subject>Methicillin-Resistant Staphylococcus aureus - genetics</subject><subject>Microbial Sensitivity Tests</subject><subject>Multilocus Sequence Typing</subject><subject>Open Reading Frames</subject><subject>Panton-Valentine leukocidin</subject><subject>Phage open reading frame typing</subject><subject>Recombinases - blood</subject><subject>SCCmec type</subject><subject>Secondary Care Centers</subject><subject>Skin - microbiology</subject><subject>Soft Tissue Infections - microbiology</subject><subject>Staphylococcus aureus</subject><subject>Staphylococcus aureus - genetics</subject><subject>Staphylococcus aureus - isolation &amp; purification</subject><subject>Teicoplanin - therapeutic use</subject><subject>Vancomycin - therapeutic use</subject><subject>Virulence Factors</subject><issn>1341-321X</issn><issn>1437-7780</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><recordid>eNqNUs2K1jAULaI4P_oCLiRLN61JkzYpiDAM6igDLkbBXUhvbvlS0x-TVPiewlc29RtduBBXN5BzTnLPOUXxjNGKUda-HKvRGahqypqKqooy9qA4Z4LLUkpFH-YzF6zkNftyVlzEOFLKZKPU4-KsblsmuejOix9Xc3KTg7D0zngStwi4Jtc779KRmNmSafEImzeBwMEEAwmDi8lBJMtAJkwHB857N5cBY74wcyJ3yayHo19gAdgiMVvAPNxMDPlgVjNjRBIRltmacCRgApLBwK8nnxSPBuMjPr2fl8Xnt28-Xd-Utx_fvb--ui2haXkqJdSDUNJ0tuMD7WnbQM85U6qV3dAp0drB2tY0oldioCCoZbIWtGtQWWTY8svixUl3Dcu3DWPSk8ure59_t2xRM9kJ0Skluv-ANlTUSjU8Q-sTNPsZY8BBr8FNeUnNqN4z06PeM9N7ZpoqnTPLpOf3-ls_of1D-R1SBrw6ATAb8t1h0BEczoDWBYSk7eL-rf_6LzrkuBwY_xWPGMdlC3O2WjMda0313d6avTSsyYXJLvCf0jHAWQ</recordid><startdate>20160101</startdate><enddate>20160101</enddate><creator>Kimura, Yumiko</creator><creator>Morinaga, Yoshitomo</creator><creator>Akamatsu, Norihiko</creator><creator>Matsuda, Junichi</creator><creator>Yamaryo, Takeshi</creator><creator>Kawakami, Kenji</creator><creator>Matsuo, Hidenori</creator><creator>Kosai, Kosuke</creator><creator>Uno, Naoki</creator><creator>Hasegawa, Hiroo</creator><creator>Yanagihara, Katsunori</creator><general>Elsevier Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>7QL</scope><scope>7T7</scope><scope>8FD</scope><scope>C1K</scope><scope>FR3</scope><scope>P64</scope></search><sort><creationdate>20160101</creationdate><title>Antimicrobial susceptibility and molecular characteristics of methicillin-resistant Staphylococcus aureus in a Japanese secondary care facility</title><author>Kimura, Yumiko ; Morinaga, Yoshitomo ; Akamatsu, Norihiko ; Matsuda, Junichi ; Yamaryo, Takeshi ; Kawakami, Kenji ; Matsuo, Hidenori ; Kosai, Kosuke ; Uno, Naoki ; Hasegawa, Hiroo ; Yanagihara, Katsunori</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c563t-7c2f487a9d93f0b065cb33188679f9846dfdd6a54b84f0c40d1724095e8de1e63</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><topic>Anti-Bacterial Agents - therapeutic use</topic><topic>Bacterial Proteins - blood</topic><topic>Bacterial Toxins</topic><topic>Community-acquired methicillin-resistant Staphylococcus aureus</topic><topic>Cross Infection - blood</topic><topic>Cross Infection - drug therapy</topic><topic>Cross Infection - microbiology</topic><topic>Daptomycin - therapeutic use</topic><topic>Dibekacin - analogs &amp; derivatives</topic><topic>Dibekacin - therapeutic use</topic><topic>Exotoxins</topic><topic>Hematology, Oncology and Palliative Medicine</topic><topic>Humans</topic><topic>Japan</topic><topic>Leukocidins</topic><topic>Linezolid - therapeutic use</topic><topic>Methicillin-Resistant Staphylococcus aureus - genetics</topic><topic>Microbial Sensitivity Tests</topic><topic>Multilocus Sequence Typing</topic><topic>Open Reading Frames</topic><topic>Panton-Valentine leukocidin</topic><topic>Phage open reading frame typing</topic><topic>Recombinases - blood</topic><topic>SCCmec type</topic><topic>Secondary Care Centers</topic><topic>Skin - microbiology</topic><topic>Soft Tissue Infections - microbiology</topic><topic>Staphylococcus aureus</topic><topic>Staphylococcus aureus - genetics</topic><topic>Staphylococcus aureus - isolation &amp; purification</topic><topic>Teicoplanin - therapeutic use</topic><topic>Vancomycin - therapeutic use</topic><topic>Virulence Factors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Kimura, Yumiko</creatorcontrib><creatorcontrib>Morinaga, Yoshitomo</creatorcontrib><creatorcontrib>Akamatsu, Norihiko</creatorcontrib><creatorcontrib>Matsuda, Junichi</creatorcontrib><creatorcontrib>Yamaryo, Takeshi</creatorcontrib><creatorcontrib>Kawakami, Kenji</creatorcontrib><creatorcontrib>Matsuo, Hidenori</creatorcontrib><creatorcontrib>Kosai, Kosuke</creatorcontrib><creatorcontrib>Uno, Naoki</creatorcontrib><creatorcontrib>Hasegawa, Hiroo</creatorcontrib><creatorcontrib>Yanagihara, Katsunori</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Industrial and Applied Microbiology Abstracts (Microbiology A)</collection><collection>Technology Research Database</collection><collection>Environmental Sciences and Pollution Management</collection><collection>Engineering Research Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><jtitle>Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Kimura, Yumiko</au><au>Morinaga, Yoshitomo</au><au>Akamatsu, Norihiko</au><au>Matsuda, Junichi</au><au>Yamaryo, Takeshi</au><au>Kawakami, Kenji</au><au>Matsuo, Hidenori</au><au>Kosai, Kosuke</au><au>Uno, Naoki</au><au>Hasegawa, Hiroo</au><au>Yanagihara, Katsunori</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Antimicrobial susceptibility and molecular characteristics of methicillin-resistant Staphylococcus aureus in a Japanese secondary care facility</atitle><jtitle>Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy</jtitle><addtitle>J Infect Chemother</addtitle><date>2016-01-01</date><risdate>2016</risdate><volume>22</volume><issue>1</issue><spage>14</spage><epage>18</epage><pages>14-18</pages><issn>1341-321X</issn><eissn>1437-7780</eissn><abstract>Abstract Methicillin-resistant Staphylococcus aureus (MRSA) is prevalent in Japan, and the Staphylococcus cassette chromosome mec (SCC mec ) type II is common among hospital-acquired MRSA isolates. Information pertaining to MRSA characteristics is limited, including SCC mec types, in primary or secondary care facilities. A total of 128 MRSA isolates (90 skin and soft tissue isolates and 38 blood isolates) were collected at a secondary care facility, Kawatana Medical Center, from 2005 to 2011. Antimicrobial susceptibility testing for anti-MRSA antibiotics and molecular testing for SCC mec and virulence genes ( tst , sec , etb , luk S/F-PV) were performed. Strains positive for luk S/F-PV were analyzed by multilocus sequence typing and phage open-reading frame typing. SCC mec typing in skin and soft tissue isolates revealed that 65.6% had type IV, 22.2% had type II, 8.9% had type I, and 3.3% had type III. In blood isolates, 50.0% had type IV, 47.4% had type II, and 2.6% had type III. Minimum inhibitory concentrations, MIC50 /MIC90 , against vancomycin, teicoplanin, linezolid, and arbekacin increased slightly in SCC mec II isolates from skin and soft tissue. MICs against daptomycin were similar between sites of isolation. SCC mec type II isolates possess tst and sec genes at a greater frequently than SCC mec type IV isolates. Four luk S/F-PV-positive isolates were divided into two clonal patterns and USA300 was not included. In conclusion, SCC mec type IV was dominant in blood, skin, and soft tissue isolates in a secondary care facility in Japan. Because antimicrobial susceptibility varies with the SCC mec type, SCC mec typing of clinical isolates should be monitored in primary or secondary care facilities.</abstract><cop>Netherlands</cop><pub>Elsevier Ltd</pub><pmid>26617349</pmid><doi>10.1016/j.jiac.2015.08.011</doi><tpages>5</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1341-321X
ispartof Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2016-01, Vol.22 (1), p.14-18
issn 1341-321X
1437-7780
language eng
recordid cdi_proquest_miscellaneous_1794498849
source ScienceDirect Freedom Collection
subjects Anti-Bacterial Agents - therapeutic use
Bacterial Proteins - blood
Bacterial Toxins
Community-acquired methicillin-resistant Staphylococcus aureus
Cross Infection - blood
Cross Infection - drug therapy
Cross Infection - microbiology
Daptomycin - therapeutic use
Dibekacin - analogs & derivatives
Dibekacin - therapeutic use
Exotoxins
Hematology, Oncology and Palliative Medicine
Humans
Japan
Leukocidins
Linezolid - therapeutic use
Methicillin-Resistant Staphylococcus aureus - genetics
Microbial Sensitivity Tests
Multilocus Sequence Typing
Open Reading Frames
Panton-Valentine leukocidin
Phage open reading frame typing
Recombinases - blood
SCCmec type
Secondary Care Centers
Skin - microbiology
Soft Tissue Infections - microbiology
Staphylococcus aureus
Staphylococcus aureus - genetics
Staphylococcus aureus - isolation & purification
Teicoplanin - therapeutic use
Vancomycin - therapeutic use
Virulence Factors
title Antimicrobial susceptibility and molecular characteristics of methicillin-resistant Staphylococcus aureus in a Japanese secondary care facility
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-29T16%3A05%3A17IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Antimicrobial%20susceptibility%20and%20molecular%20characteristics%20of%20methicillin-resistant%20Staphylococcus%20aureus%20in%20a%20Japanese%20secondary%20care%20facility&rft.jtitle=Journal%20of%20infection%20and%20chemotherapy%20:%20official%20journal%20of%20the%20Japan%20Society%20of%20Chemotherapy&rft.au=Kimura,%20Yumiko&rft.date=2016-01-01&rft.volume=22&rft.issue=1&rft.spage=14&rft.epage=18&rft.pages=14-18&rft.issn=1341-321X&rft.eissn=1437-7780&rft_id=info:doi/10.1016/j.jiac.2015.08.011&rft_dat=%3Cproquest_cross%3E1794498849%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c563t-7c2f487a9d93f0b065cb33188679f9846dfdd6a54b84f0c40d1724095e8de1e63%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1750428853&rft_id=info:pmid/26617349&rfr_iscdi=true